Fast and sensitive delineation of brain tumor with clinically compatible moxifloxacin labeling and confocal microscopy (J. Biophotonics 1/2020)

Inside Front Cover: Fast and sensitive delineation of brain tumor with clinically compatible moxifloxacin labeling and confocal microscopy (J. Biophotonics 1/2020):

A new high‐speed cellular imaging method using clinically applicable moxifloxacin labeling, called as moxifloxacin based confocal microscopy (MBCM), was developed for fast and sensitive tumor detection and delineation. The MBCM demarcated malignant brain tumor from normal brain by visualizing dense and irregular cell distribution in the tumor. An image processing algorithm was developed for automated brain tumor detection.

Further details can be found in the article by Seunghun Lee, Won Yeong Park, Hoonchul Chang, et al. (e201900197).






A new high‐speed cellular imaging method using clinically applicable moxifloxacin labeling, called as moxifloxacin based confocal microscopy (MBCM), was developed for fast and sensitive tumor detection and delineation. The MBCM demarcated malignant brain tumor from normal brain by visualizing dense and irregular cell distribution in the tumor. An image processing algorithm was developed for automated brain tumor detection.

Further details can be found in the article by Seunghun Lee, Won Yeong Park, Hoonchul Chang, et al. (e201900197).